- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06108778
Incidence of Metabolic Disorders in Neonatal Convulsions
November 6, 2023 updated by: Amira Mohamed Sayed Ahmed, Assiut University
Adescriptive Study on Incidence of Metabolic Disorders in Neonatal Convulsions
Describe the incidence of metabolic disorders in neonatal convulsions affecting neonates at NICU Describe types of metabolic disorders causing neonatal convulsions
Study Overview
Detailed Description
Neonates are susceptible to seizures due to several physiologic factors and combination of risks that are uniquely associated with gestation, delivery,and the immediate postnatal period.
Neonatal seizures can be challenging to identify therefore itis imperative that clinicians have ahigh degree of suspicion for seizures based on the clinical history or the presence of encephalopathy with or without paroxysmal abnormal movements.
Acute symptomatic neonatal seizures are due to an acute brain injury, whereas neonatal onset_epilepsy may be due to underlying structural, metabolic ,or genetic disorders.Early identification and treatment are likely important for long term outcomes in acute symptomatic seizures though additional studies are needed to understand optimal seizure control metrics and the ideal duration of treatment.
seizures may be the first and the major presenting feature of an inborn error of metabolism.
seizures may be preceded by other major symptoms by areduced level of consciousness in achild with an organic acidemia or urea cycle defect or by loss of skills ,progressive weakness ,ataxia ,and upper motor signs in achild with lysosomal storage disorder or peroxisomal leukodystrophy.the
metabolic causes of seizure vary according to age at presentation.
Study Type
Observational
Enrollment (Estimated)
115
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Amira Mohamed Sayed, master
- Phone Number: 01140282846
- Email: amiramohamed12yahoo@gmail.com
Study Contact Backup
- Name: Abdellatif Mohamed Abdelmoaz, professor
- Phone Number: 01005208016
- Email: a.m.abdelmoez@aun.edu.eg
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Neonates with convulsions due to metabolic diseases
Description
Inclusion Criteria:
- Neonatal convulsions associated with vomiting,acidotic breathing,DCL,change of body tone or change in hair color
- Abnormal metabolic investigations (elevated serum ammonia and lactate ,persistent metabolic acidosis,abnormal metabolic screening and hypoglycemia
- persistent neonatal convulsions not respond to antiepileptic drugs
Exclusion Criteria:
- History of neonatal asphyxia
- History of birth trauma
- Signs of sepsis and CNS infection
- Neonate with electrolyte disturbance
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Describe incidence of metabolic disorders in neonatal convulsions affecting neonates at NICU
Time Frame: Baseline
|
Describe types of metabolic disorders causing neonatal convulsions
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Russ JB, Simmons R, Glass HC. Neonatal Encephalopathy: Beyond Hypoxic-Ischemic Encephalopathy. Neoreviews. 2021 Mar;22(3):e148-e162. doi: 10.1542/neo.22-3-e148.
- Stomnaroska O, Petkovska E, Jancevska S, Danilovski D. Neonatal Hypoglycemia: Risk Factors and Outcomes. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2017 Mar 1;38(1):97-101. doi: 10.1515/prilozi-2017-0013.
- Balakrishnan U, Chandrasekaran A, Amboiram P, Ninan B, Ignatious S. Outcome of Inherited Metabolic Disorders Presenting in the Neonatal Period. Indian J Pediatr. 2021 May;88(5):455-462. doi: 10.1007/s12098-020-03522-6. Epub 2020 Oct 14.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
November 25, 2023
Primary Completion (Estimated)
December 25, 2024
Study Completion (Estimated)
February 25, 2025
Study Registration Dates
First Submitted
October 25, 2023
First Submitted That Met QC Criteria
October 25, 2023
First Posted (Actual)
October 31, 2023
Study Record Updates
Last Update Posted (Actual)
November 7, 2023
Last Update Submitted That Met QC Criteria
November 6, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Neonatal convulsions
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neonatal Convulsions
-
Assiut UniversityNot yet recruitingNeonatal Convulsion
-
Centre Hospitalier Universitaire DijonCompletedInfants Likely to Present Febrile ConvulsionsFrance
-
Karolinska InstitutetCompletedHypoxic Ischemic Encephalopathy | Neonatal Convulsions | Subgaleal HematomaSweden
-
HaEmek Medical Center, IsraelCompleted
-
Assiut UniversityNot yet recruitingFebrile Convulsion
-
Assiut UniversityNot yet recruiting
-
Medical University InnsbruckCompleted
-
Queen Sirikit National Institute of Child HealthRecruitingRecurrent Febrile ConvulsionThailand
-
Kamuzu University of Health SciencesTerminatedStatus Epilepticus | ConvulsionsMalawi
-
Kamuzu University of Health SciencesCompletedStatus Epilepticus | ConvulsionsMalawi
Clinical Trials on MRI
-
Assistance Publique Hopitaux De MarseilleActive, not recruitingMultiple SclerosisFrance
-
Cambridge University Hospitals NHS Foundation TrustRecruitingBreast CancerUnited Kingdom
-
Seoul National University Bundang HospitalBayerCompletedTraumaKorea, Republic of
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedOsteosarcoma | Ewing Sarcoma | Paget's DiseaseUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedAdult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
University of EdinburghActive, not recruiting
-
Assistance Publique - Hôpitaux de ParisUnknownBrain Injury, Coma | Cardiac Arrest (CA) | Traumatic Brain Injury (TBI) | Aneurysmal Subarachnoid Hemorrhages (aSAH)France
-
Sheba Medical CenterUnknown
-
University of ZurichBalgrist University HospitalNot yet recruiting
-
Bragee ClinicsNot yet recruitingChronic Fatigue Syndrome